A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD

NCT04812262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity
Type2 Diabetes
NAFLD

Interventions

DRUG: DD01
DRUG: Placebo

Sponsor

Neuraly, Inc.